- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Reforming Oncology Care Payments: Interviews From the QCCA Leadership Summit
As the costs of cancer care continue to rise in the United States, eyes are increasingly turning to payment reform.
As the costs of cancer care continue to rise in the United States, eyes are increasingly turning to payment reform. Research by the Northeast Business Group on Health found that in 2015, employers spent $125 million on cancer care, and since then, cancer therapy costs have increased substantially with greater use of immunotherapy and the introduction of chimeric antigen receptor T-cell therapies that can easily cost half a million dollars for treatment.
The federal government is taking the lead with the Oncology Care Model, which will transition into Oncology Care First in 2022 after a 1-year extension due to the coronavirus disease 2019 pandemic, but commercial payers are also testing payment reform models.
Speakers who participated in the Quality Cancer Care Alliance’s Fall Leadership Summit weighed in on the payment reform space for cancer care.
Listen above or through one of these podcast services:
Read more:
Speaking of Employers: Purchasers Detail the Challenges of Getting a Handle on Oncology Care Costs
Three Ways COVID-19 Makes the Oncology Care First Model More Attractive
Infrastructure of OCM Helps Practices Through COVID-19, Chong Says
A Closer Look at 3 Oncology Payment Reform Projects
Cancer Does Not Stop for COVID-19, but Reform Becomes a Challenge
Designing Care for the Underserved Creates Higher-Value Health Solutions
January 12th 2025In the second half of our interview with Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine, she discusses effective engagement of minoritized populations in discussion of medical mistrust.
Read More
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More
